Is it correct that the original patent is a Greek patent or is there a separate U.S. version as well?
"ARTICLE I - TRANSFER OF PATENTS
1.1. By the present contract the Assignor, unreservedly and without any exception, concedes and transfers to the Assignee, which accepts, all the rights of property and use of the following:
a) Greek Patent no 1002616/ February 20, 1997 (Application registered in the Greek National Office of Industrial Property on February 21, 1996 under the number 960100061) and title: “Synthesis and method of synthesis of molecule Tetrahydro - N,N - dimethyl - 2,2 - diphenyl - 3 - furanemethanamine (AE 37), with anticonvulsant, antidepressant and nootropic activity”.
b) Greek Patent no 1004208/ April 4, 2003 (Application registered in the Greek National Office of Industrial Property on October 15,2001 under the number 20010100476) and title: “Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, with synergic sigma/muscarinic (neuroactivating) and sigma/sodium channel (neuroprotective) components, as prototypical activating – neuroprotectors and neuroregenerative drugs”.
c) Greek Patent no 1004868/ April 26, 2005 (Application registered in the Greek National Office of Industrial Property on April 22, 2003 under the number 20030100190) and title: “Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromodulating and neuroregenerative drugs”.
d) Greek Patent application no 20070100020/January 17, 2007. Registered in the Greek National Office of Industrial Property under the title: “New sigma (s) receptor ligands with anti-apoptotic and/or pro-apoptotic properties over cellular biochemical mechanisms, with neuroprotective, anti-cancer, anti-metastatic and anti-(chronic) inflammatory action”.
Including all rights to the Inventions described in the Patents. In addition Assignor warrants that there are 8 compounds in pre-clinical stages which are derivatives of the Patents as listed in Schedule “A” attached.
1.2. Consequently by means of this agreement, the Assignee finds itself in the position of surrogate owner of all the rights of the Assignor to the Patent inventions, so that it will have the full and entire ownership and use of the Patents and the power to use or to exploit it as it pleases.
-3-
1.3. The Assignor warrants as of the date of execution of this contract, the Patents are free of any right of any third person and from any claim to ownership, total or partial, of any kind and from any lien, charge, actions or proceedings.
1.4. The present transfer is taking place under the sole guarantee of the material existence of the Greek Patents."
News 
Market Data 
Discover 
